Latest News
May 2022 MIP Diagnostics, a leading UK nanotechnology firm has today rebranded to MIP Discovery as the business continues its ...
Upperton Pharma Solutions (Upperton), a UK-based specialist contract development and manufacturing organisation (CDMO), has announced a circa. £15m investment into ...
Nottingham-based contract research organisation (CRO) Reach Separations has reported a significant increase in turnover in the wake of sustained demand ...
Recognized as a leading technology company by How2Media for its recombinant antibodies Redcar, UK, May 12, 2022. Absolute Antibody Ltd., an ...
Amphista and Bristol Myers Squibb to collaborate and leverage Amphista’s proprietary Eclipsys™ targeted protein degradation platform to develop novel protein ...
Sygnature have acquired Peak Proteins Ltd. Following an extensive partnership between the two companies, this deal will enable seamless integration of protein ...
Financing led by new investors, GV, Northpond Ventures and Sanofi Ventures, with existing investors, Syncona, Oxford Science Enterprises, and Oxford ...
BioCity Nottingham-based marketing and PR agency V Formation is celebrating its fifteenth birthday amidst sustained growth and new plans for ...
BioCity, Scotland, 26th April 2022 Invizius Limited (“Invizius”), a biotechnology company developing treatments to suppress unwanted immune responses in haemodialysis, today ...
